Your browser doesn't support javascript.
loading
Pharmacokinetic and Pharmacodynamic Evaluation following Vaginal Application of IQB3002, a Dual-Chamber Microbicide Gel Containing the Nonnucleoside Reverse Transcriptase Inhibitor IQP-0528 in Rhesus Macaques.
Pereira, Lara E; Mesquita, Pedro M M; Ham, Anthony; Singletary, Tyana; Deyounks, Frank; Martin, Amy; McNicholl, Janet; Buckheit, Karen W; Buckheit, Robert W; Smith, James M.
Afiliação
  • Pereira LE; LifeSource Biomedical LLC, Moffett Field, California, USA.
  • Mesquita PM; Albert Einstein College of Medicine, Bronx, New York, USA.
  • Ham A; ImQuest BioSciences, Frederick, Maryland, USA.
  • Singletary T; Anyar Inc., Fort Walton Beach, Florida, USA.
  • Deyounks F; Total Solutions, Inc., Madison, Alabama, USA.
  • Martin A; Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, Georgia, USA.
  • McNicholl J; Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, Georgia, USA.
  • Buckheit KW; ImQuest BioSciences, Frederick, Maryland, USA.
  • Buckheit RW; ImQuest BioSciences, Frederick, Maryland, USA.
  • Smith JM; Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, Georgia, USA ajo9@cdc.gov.
Antimicrob Agents Chemother ; 60(3): 1393-400, 2015 Dec 14.
Article em En | MEDLINE | ID: mdl-26666935
ABSTRACT
We evaluated the in vivo pharmacokinetics and used a complementary ex vivo coculture assay to determine the pharmacodynamics of IQB3002 gel containing 1% IQP-0528, a nonnucleoside reverse transcriptase inhibitor (NNRTI), in rhesus macaques (RM). The gel (1.5 ml) was applied vaginally to 6 simian-human immunodeficiency (SHIV)-positive female RM. Blood, vaginal fluids, and rectal fluids were collected at 0, 1, 2, and 4 h. RM were euthanized at 4 h, and vaginal, cervical, rectal, and regional lymph node tissues were harvested. Anti-human immunodeficiency virus (HIV) activity was evaluated ex vivo by coculturing fresh or frozen vaginal tissues with activated human peripheral blood mononuclear cells (PBMCs) and measuring the p24 levels for 10 days after an HIV-1Ba-L challenge. The median levels of IQP-0528, determined using liquid chromatography-tandem mass spectroscopy (LC-MS/MS) methods, were between 10(4) and 10(5) ng/g in vaginal and cervical tissue, between 10(3) and 10(4) ng/g in rectal tissues, and between 10(5) and 10(7) ng/ml in vaginal fluids over the 4-h period. The vaginal tissues protected the cocultured PBMCs from HIV-1 infection ex vivo, with a viral inhibition range of 81 to 100% in fresh and frozen tissues that were proximal, medial, and distal relative to the cervix. No viral inhibition was detected in untreated baseline tissues. Collectively, the median drug levels observed were 5 to 7 logs higher than the in vitro 50% effective concentration (EC50) range (0.21 ng/ml to 1.29 ng/ml), suggesting that 1.5 ml of the gel delivers IQP-0528 throughout the RM vaginal compartment at levels that are highly inhibitory to HIV-1. Importantly, antiviral activity was observed in both fresh and frozen vaginal tissues, broadening the scope of the ex vivo coculture model for future NNRTI efficacy studies.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Pirimidinonas / Inibidores da Transcriptase Reversa Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Pirimidinonas / Inibidores da Transcriptase Reversa Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article